NCT07294482 The Effects on Sleep Quality of 1:4 Reishi Liquid Extract
| NCT ID | NCT07294482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Efforia, Inc |
| Condition | Sleep |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-09-10 |
| Primary Completion | 2026-09-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-09-10 with a primary completion date of 2026-09-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Examining the effects of 1ml of Reishi mushroom extract (1:4 extraction ratio, two hot water extractions and an alcohol extraction), taken daily, 30 mins before bed on perceived sleep quality and stress levels. Sleep quality includes: duration, sleep onset latency, nighttime wakings, and perceived restfulness. And consequently, the potential for increased daytime energy levels and a reduction in perceived stress levels.
Eligibility Criteria
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with Allergies * Pregnant or Nursing Women * Individuals on Anticoagulants * Immunocompromised Individuals * Individuals with Liver Disease * Children and Adolescents * Individuals with Chronic Illnesses * Those with Mental Health Disorders
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07294482 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07294482 currently recruiting?
Yes, NCT07294482 is actively recruiting participants. Contact the research team at help@efforia.com for enrollment information.
Where is the NCT07294482 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT07294482 clinical trial?
NCT07294482 is sponsored by Efforia, Inc. The trial plans to enroll 100 participants.